Jackson Richard L.

CIK 00014188721 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001418872

Recent Transactions

32 trades

Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2016-06-24+54,347→ 54,347 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2016-06-06+2,723→ 12,649 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2016-06-06−2,723→ 0 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2016-06-06$7.38/sh−681→ 11,968 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2015-09-24+14,245→ 14,245 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2015-06-13$3.88/sh−4,011→ 59,557 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2015-06-13−16,042→ 0 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2015-06-13+16,042→ 63,568 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2015-06-12+12,886→ 12,886 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2014-03-11$3.65/sh−4,838→ 49,570 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2014-03-11−19,352→ 0 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2014-03-11+19,352→ 54,408 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2013-06-13+16,042→ 16,042 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2013-06-09$1.86/sh−1,135→ 35,056 total
Award
Cascadian Therapeutics, Inc.
Common Stock
2012-06-07$3.67/sh+8,174→ 36,191 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2012-06-03$3.51/sh−2,021→ 28,017 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Units
2012-05-03−989→ 0 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2012-05-03$4.15/sh−247→ 30,038 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2012-05-03+989→ 30,285 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2011-12-31+2,388→ 29,893 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2011-12-31$7.58/sh−597→ 29,296 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Units
2011-12-31−2,388→ 0 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2011-12-04$6.86/sh−1,546→ 27,505 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2011-06-12+2,076→ 29,051 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Units
2011-06-12−2,076→ 0 total
Award
Cascadian Therapeutics, Inc.
Common Stock
2011-06-09+4,538→ 26,975 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2010-12-14+3,166→ 22,437 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Units
2010-12-14−3,166→ 0 total
Award
Cascadian Therapeutics, Inc.
Common Stock
2010-06-03+8,086→ 19,271 total
Award
Cascadian Therapeutics, Inc.
Common Stock
2009-12-04+6,185→ 11,185 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Units
2009-03-11+19,352→ 19,352 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Units
2009-03-11+21,428→ 21,428 total

Companies

Cascadian Therapeutics, Inc.
Director

Recent Filings

Address

2601 FOURTH AVENUE SUITE 500

SEATTLE, WA, 98121

View on SEC.gov